Abstract
The ageing population and the increasing prevalence of noncommunicable diseases such as diabetes and hypertension have led to an increased prevalence of chronic kidney disease. The generation of de novo kidney tissue from embryonic tissue and stem cells using tissue engineering approaches is being explored as an alternative to renal replacement therapy for treating the disease. It is, however, becoming clear that resident cells can not only induce fibrotic repair, but can also restore damaged kidney tissue. Mobilizing this innate capacity of the kidney to regenerate is of particular interest in the prevention of irreversible kidney failure. A novel concept is that the interaction of interstitial stromal cells with the local immune system may regulate tissue homeostasis and the balance between tissue repair and fibrosis. Mesenchymal stromal cells (MSCs), in particular, may enhance the intrinsic reparative capabilities of the kidney. This Perspectives article considers the innate regenerative potential of the kidney in the context of ongoing studies of MSC therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bonventre, J. V. & Yang, L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121, 4210–4221 (2011).
Romagnani, P., Lasagni, L. & Remuzzi, G. Renal progenitors: an evolutionary conserved strategy for kidney regeneration. Nat. Rev. Nephrol. 9, 137–146 (2013).
Smeets, B. et al. Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J. Pathol. 229, 645–659 (2012).
Oliver, J. A., Maarouf, O., Cheema, F. H., Martens, T. P. & Al-Awqati, Q. The renal papilla is a niche for adult kidney stem cells. J. Clin. Invest. 114, 795–804 (2004).
Humphreys, B. D. et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2, 284–291 (2008).
Eggenhofer, E. et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front. Immunol. 3, 297 (2012).
Togel, F. E. & Westenfelder, C. Kidney protection and regeneration following acute injury: progress through stem cell therapy. Am. J. Kidney Dis. 60, 1012–1022 (2012).
Vogetseder, A. et al. Proliferation capacity of the renal proximal tubule involves the bulk of differentiated epithelial cells. Am. J. Physiol. Cell Physiol. 294, C22–C28 (2008).
Humphreys, B. D. et al. Repair of injured proximal tubule does not involve specialized progenitors. Proc. Natl Acad. Sci. USA 108, 9226–9231 (2011).
Angelotti, M. L. et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30, 1714–1725 (2012).
Rumballe, B., Georgas, K., Wilkinson, L. & Little, M. Molecular anatomy of the kidney: what have we learned from gene expression and functional genomics? Pediatr. Nephrol. 25, 1005–1016 (2010).
Wingert, R. A. & Davidson, A. J. The zebrafish pronephros: a model to study nephron segmentation. Kidney Int. 73, 1120–1127 (2008).
Ward, H. H. et al. Adult human CD133/1+ kidney cells isolated from papilla integrate into developing kidney tubules. Biochim. Biophys. Acta 1812, 1344–1357 (2011).
Bussolati, B. et al. Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Am. J. Physiol. Renal Physiol. 302, F116–F128 (2012).
Lindgren, D. et al. Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am. J. Pathol. 178, 828–837 (2011).
Sagrinati, C. et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J. Am. Soc. Nephrol. 17, 2443–2456 (2006).
Ronconi, E. et al. Regeneration of glomerular podocytes by human renal progenitors. J. Am. Soc. Nephrol. 20, 322–332 (2009).
Rae, F. et al. Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. Dev. Biol. 308, 232–246 (2007).
Sicking, E. M. et al. Subtotal ablation of parietal epithelial cells induces crescent formation. J. Am. Soc. Nephrol. 23, 629–640 (2012).
Smeets, B. et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J. Am. Soc. Nephrol. 20, 2604–2615 (2009).
Abbate, M., Brown, D. & Bonventre, J. V. Expression of NCAM recapitulates tubulogenic development in kidneys recovering from acute ischemia. Am. J. Physiol. 277, F454–F463 (1999).
Witzgall, R., Brown, D., Schwarz, C. & Bonventre, J. V. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J. Clin. Invest. 93, 2175–2188 (1994).
Grgic, I. et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int. 82, 172–183 (2012).
Yang, L., Humphreys, B. D. & Bonventre, J. V. Pathophysiology of acute kidney injury to chronic kidney disease: maladaptive repair. Contrib. Nephrol. 174, 149–155 (2011).
Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V. & Bonventre, J. V. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat. Med. 16, 535–543, (2010).
Maeshima, A., Yamashita, S. & Nojima, Y. Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J. Am. Soc. Nephrol. 14, 3138–3146 (2003).
Adams, D. C. & Oxburgh, L. The long-term label retaining population of the renal papilla arises through divergent regional growth of the kidney. Am. J. Physiol. Renal Physiol. 297, F809–F815 (2009).
Song, J. et al. Characterization and fate of telomerase-expressing epithelia during kidney repair. J. Am. Soc. Nephrol. 22, 2256–2265 (2011).
Crisan, M. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301–313 (2008).
Meirelles, L. S. & Nardi, N. B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br. J. Haematol. 123, 702–711 (2003).
Pelekanos, R. A. et al. Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities. Stem Cell Res. 8, 58–73 (2012).
Alikhan, M. A. et al. Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am. J. Pathol. 179, 1243–1256 (2011).
Zhang, M. Z. et al. CSF-1 signaling mediates recovery from acute kidney injury. J. Clin. Invest. 122, 4519–4532 (2012).
Maggini, J. et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS ONE 5, e9252 (2010).
Proebstl, D. et al. Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J. Exp. Med. 209, 1219–1234 (2012).
Augustin, H. G., Koh, G. Y., Thurston, G. & Alitalo, K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 10, 165–177 (2009).
Rabelink, T. J., Wijewickrama, D. C. & de Koning, E. J. Peritubular endothelium: the Achilles heel of the kidney? Kidney Int. 72, 926–930 (2007).
Frenette, P. S., Pinho, S., Lucas, D. & Scheiermann, C. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu. Rev. Immunol. 31, 285–316 (2013).
Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85–97 (2010).
Li, J., Deane, J. A., Campanale, N. V., Bertram, J. F. & Ricardo, S. D. The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells 25, 697–706 (2007).
Rabelink, T. J., de Boer, H. C. & van Zonneveld, A. J. Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat. Rev. Nephrol. 6, 404–414 (2010).
Perin, E. C. et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 307, 1717–1726 (2012).
Traverse, J. H. et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 306, 2110–2119 (2011).
Traverse, J. H. et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 308, 2380–2389 (2012).
Bi, B., Schmitt, R., Israilova, M., Nishio, H. & Cantley, L. G. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 18, 2486–2496 (2007).
Imberti, B. et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J. Am. Soc. Nephrol. 18, 2921–2928 (2007).
Bianco, P. et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19, 35–42 (2013).
Salmi, M. & Jalkanen, S. Cell-surface enzymes in control of leukocyte trafficking. Nat. Rev. Immunol. 5, 760–771 (2005).
Bruno, S. et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20, 1053–1067 (2009).
Bruno, S. et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS ONE 7, e33115 (2012).
Deregibus, M. C., Tetta, C. & Camussi, G. The dynamic stem cell microenvironment is orchestrated by microvesicle-mediated transfer of genetic information. Histol. Histopathol. 25, 397–404 (2010).
Wang, Y., He, J., Pei, X. & Zhao, W. Systematic review and meta-analysis of mesenchymal stem/stromal cells therapy for impaired renal function in small animal models. Nephrology (Carlton) 18, 201–208 (2013).
Franquesa, M. et al. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev. 21, 3125–3135 (2012).
Devine, S. M., Cobbs, C., Jennings, M., Bartholomew, A. & Hoffman, R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101, 2999–3001 (2003).
Kunter, U. et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J. Am. Soc. Nephrol. 18, 1754–1764 (2007).
Reinders, M. E., Fibbe, W. E. & Rabelink, T. J. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol. Dial. Transplant. 25, 17–24 (2010).
AlloCure. AlloCure begins phase 2 clinical trial in acute kidney injury [online], (2013).
Tan, J. et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307, 1169–1177 (2012).
Reinders, M. E. et al. Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy. Cytotherapy 15, 663–672 (2013).
Reinders, M. E. et al. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl. Med. 2, 107–111 (2013).
Takahashi-Iwanaga, H. The three-dimensional cytoarchitecture of the interstitial tissue in the rat kidney. Cell Tissue Res. 264, 269–281 (1991).
Acknowledgements
We thank Kylie Georgas, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia for assistance with illustrations. Our research has received funding from the European Community's Seventh Framework Program (FP7/2007–2013) under grant agreement number 305436. M. H. Little is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow and her work in this area is supported by the NHMRC (APP1054985).
Author information
Authors and Affiliations
Contributions
T. J. Rabelink and M. H. Little contributed equally to discussion of content for the article, researching data to include in the manuscript, and writing, reviewing and editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Rabelink, T., Little, M. Stromal cells in tissue homeostasis: balancing regeneration and fibrosis. Nat Rev Nephrol 9, 747–753 (2013). https://doi.org/10.1038/nrneph.2013.152
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.152
This article is cited by
-
Potential functions and therapeutic implications of glioma-resident mesenchymal stem cells
Cell Biology and Toxicology (2023)
-
Mesenchymal stromal cells in lupus nephritis
Nature Reviews Nephrology (2017)
-
Understanding kidney morphogenesis to guide renal tissue regeneration
Nature Reviews Nephrology (2016)
-
Preparing the ground for tissue regeneration: from mechanism to therapy
Nature Medicine (2014)
-
Immune system modulation of kidney regeneration—mechanisms and implications
Nature Reviews Nephrology (2014)